Catalog No.:AA00C5L3

332026-86-5 | 4-(1H-Benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine

Name: Name:4-(1H-Benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine
Brand: AABLOCKS
SKU: AA00C5L3
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

250mg

98%

in stock

$12.00 $8.00

- +

98%

in stock

$29.00 $21.00

- +

98%

in stock

$93.00 $65.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA00C5L3

Chemical Name:

4-(1H-Benzimidazol-2-yl)-1,2,5-oxadiazol-3-amine

CAS Number:

332026-86-5

Molecular Formula:

C9H7N5O

Molecular Weight:

201.1848

MDL Number:

MFCD00501862

SMILES:

Nc1nonc1c1nc2c([nH]1)cccc2

Properties

Form:

Solid

Computed Properties

Complexity:

239

Covalently-Bonded Unit Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

XLogP3:

0.7

Downstream Synthesis Route

332026-86-5

3-amino-4-(1-ethyl-1H-benzodimidazol-2-yl)-1,2,5-oxadiazole

[1]Sergievskii;Krasnoshek;Mel'nikova;Tselinskii[RussianJournalofOrganicChemistry,2002,vol.38,#6,p.872-874]

[2]Stepanov,AndreiI.;Astrat'ev,AlexanderA.;Sheremetev,AlekseiB.;Lagutina,NataliyaK.;Palysaeva,NadezhdaV.;Tyurin,AlekseiYu.;Aleksandrova,NataliyaS.;Sadchikova,NataliyaP.;Suponitsky,KyrillYu.;Atamanenko,OlgaP.;Konyushkin,LeonidD.;Semenov,RomanV.;Firgang,SergeiI.;Kiselyov,AlexS.;Semenova,MarinaN.;Semenov,VictorV.[EuropeanJournalofMedicinalChemistry,2015,vol.94,p.237-251]

107-13-1

332026-86-5

798578-48-0

[1]CurrentPatentAssignee:YUNNANBAIYAOGROUPCO.,LTD.;YUNBAIYAOZHENGWUSCIENTSHANGHAI-CN111454254,2020,ALocationinpatent:Paragraph0038-0044

[2]CurrentPatentAssignee:BASILEAPHARMACEUTICA-WO2011/12577,2011,A1Locationinpatent:Page/Pagecolumn29;31;32

[3]CurrentPatentAssignee:BASILEAPHARMACEUTICA-WO2004/103994,2004,A1Locationinpatent:Page41

63823-75-6

332026-86-5

[1]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN109265451,2019,ALocationinpatent:Paragraph0032;0033;0034

[2]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN112920178,2021,ALocationinpatent:Paragraph0021;0032-0034

[3]Li,Qi;Xing,Shuaishuai;Chen,Ying;Liao,Qinghong;Xiong,Baichen;He,Siyu;Lu,Weixuan;Liu,Yang;Yang,Hongyu;Li,Qihang;Feng,Feng;Liu,Wenyuan;Chen,Yao;Sun,Haopeng[JournalofMedicinalChemistry,2020,vol.63,#17,p.10030-10044]

[4]CurrentPatentAssignee:BASILEAPHARMACEUTICA-WO2011/12577,2011,A1Locationinpatent:Page/Pagecolumn29;31

[5]Li,Qi;Chen,Ying;Xing,Shuaishuai;Liao,Qinghong;Xiong,Baichen;Wang,Yuanyuan;Lu,Weixuan;He,Siyu;Feng,Feng;Liu,Wenyuan;Chen,Yao;Sun,Haopeng[JournalofMedicinalChemistry,2021,vol.64,#10,p.6856-6876]

3289-76-7

332026-86-5

2-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1H-benzodimidazol-1-yl)-N-(2-chlorophenyl)acetamide

[1]Stepanov,AndreiI.;Astrat'ev,AlexanderA.;Sheremetev,AlekseiB.;Lagutina,NataliyaK.;Palysaeva,NadezhdaV.;Tyurin,AlekseiYu.;Aleksandrova,NataliyaS.;Sadchikova,NataliyaP.;Suponitsky,KyrillYu.;Atamanenko,OlgaP.;Konyushkin,LeonidD.;Semenov,RomanV.;Firgang,SergeiI.;Kiselyov,AlexS.;Semenova,MarinaN.;Semenov,VictorV.[EuropeanJournalofMedicinalChemistry,2015,vol.94,p.237-251]

[2]Li,Qi;Chen,Ying;Xing,Shuaishuai;Liao,Qinghong;Xiong,Baichen;Wang,Yuanyuan;Lu,Weixuan;He,Siyu;Feng,Feng;Liu,Wenyuan;Chen,Yao;Sun,Haopeng[JournalofMedicinalChemistry,2021,vol.64,#10,p.6856-6876]

332026-86-5

3-amino-4-1-(naphthalen-1-ylmethyl)-1H-benzimidazol-2-yl-furazan

Literature

Title: 4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20090901

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS